PERRIGO Co plc SEC filings PRGO
PERRIGO Co plc has 1,003 filings in SEC EDGAR's recent list, going back to Mar 7, 2016. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 24, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 12, 2026 | — |
| 11-K | Employee savings plan report | Jun 26, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 16, 2025 | — |
| 25-NSE | Delisting notice | Dec 16, 2024 | — |
| CERT | Nyse certification | Oct 10, 2024 | — |
| 8-A12B | Filing | Oct 7, 2024 | — |
| 25-NSE | Delisting notice | Oct 2, 2024 | — |
| 11-K | Employee savings plan report | Jun 25, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2023 | — |
| CORRESP | Letter to the SEC | Sep 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 25, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| 11-K | Employee savings plan report | Jun 20, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 16, 2023 | — |
| 11-K | Employee savings plan report | Jun 22, 2022 | Dec 31, 2021 |
| 25-NSE | Delisting notice | May 20, 2022 | — |
| PRER14A | Filing | Mar 11, 2022 | — |
| 11-K | Employee savings plan report | Jun 25, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2021 | — |
| 25-NSE | Delisting notice | Jul 6, 2020 | — |
| 25-NSE | Delisting notice | Jul 6, 2020 | — |
| 11-K | Employee savings plan report | Jun 23, 2020 | Dec 31, 2019 |
| 11-K | Employee savings plan report | Jun 19, 2019 | Dec 31, 2018 |
| 11-K | Employee savings plan report | Jun 19, 2018 | Dec 31, 2017 |
| 11-K | Employee savings plan report | Jun 29, 2017 | Dec 31, 2016 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2017 | — |
| NT 10-Q | Filing | May 11, 2017 | Apr 1, 2017 |
| 25-NSE | Delisting notice | May 9, 2017 | — |
| NT 10-K | Filing | Feb 27, 2017 | Feb 27, 2017 |
| NT 10-Q | Filing | Feb 27, 2017 | Feb 27, 2017 |
| UPLOAD | Letter from the SEC | Nov 21, 2016 | — |
| CERTNYS | Auto-generated paper document | Nov 17, 2016 | — |
| CERTNYS | Auto-generated paper document | Nov 17, 2016 | — |
| 8-A12B | Filing | Nov 16, 2016 | — |
| 8-A12B | Filing | Nov 16, 2016 | — |
| CERTNYS | Auto-generated paper document | Nov 14, 2016 | — |
| CORRESP | Letter to the SEC | Nov 14, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2016 | — |
| CORRESP | Letter to the SEC | Oct 14, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2016 | — |
| 11-K | Employee savings plan report | Jun 27, 2016 | Dec 31, 2015 |
| SD | Specialized disclosure (conflict minerals) | May 24, 2016 | — |
| NT 10-Q | Filing | May 13, 2016 | Apr 2, 2016 |
| NO ACT | Auto-generated paper document | Mar 17, 2016 | Mar 17, 2016 |
| NO ACT | Auto-generated paper document | Mar 16, 2016 | Mar 15, 2016 |
| NO ACT | Auto-generated paper document | Mar 14, 2016 | Mar 3, 2016 |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRGO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin 2, Ireland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1585364
- Former names
- PERRIGO Co Ltd (until Nov 12, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.